Last synced from Twitter 84d ago
insitro Announces Five-Year Discovery Collaboration with Bristol Myers Squibb to Discover and Develop Novel Treatments for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
insitro, a machine-learning driven drug discovery and development company, today announced that it has entered into a five-year, discovery collaborati
A Nobel for CRISPR! When, Who, How, What Now - 16 Minutes News by a16z
"It's CRISPR!" This week, the Nobel Prize in Chemistry was awarded to scientists Emmanuelle Charpentier and Jennifer Doudna (also an a16z co-founder, of Scribe Therapeutics), for the development of the CRISPR/Cas9 method for genome editing...
Force-Field Functor Theory: Classical Force-Fields which Reproduce Equilibrium Quantum Distributions
Feynman and Hibbs were the first to variationally determine an effective
potential whose associated classical canonical ensemble approximates the exact
quantum partition function. We examine the existence of a map between the local
potential and an...
insitro Strengthens Machine Learning-Based Drug Discovery Capabilities with Acquisition of Haystack Sciences
insitro, a machine learning driven drug discovery and development company, today announced the acquisition of Haystack Sciences, a private company adv
Genentech taps Stanford University spinout for AI drug discovery partnership
Genentech has tapped an artificial intelligence startup spun out of Stanford University late last year to help it discover new drugs across multiple therapeutic targets.
3
Vijay Pande
Congratulations @enfeinberg and Genesis Therapeutics for their recent partnership deal with Genetech/Roche!
94d
Are We Ready for Cures? - Andreessen Horowitz
COVID-19 has been a massive disruption to our system. But there’s another one coming. We’re in the middle of a fundamental shift in healthcare which will require major change across the entire landscape: our increasing ability to fix the underlying...
Bio Eats World: Biology by Design - Andreessen Horowitz
We’re at the dawn of a new era where we’re truly able to design biology: from genetically engineered cotton, to meat made from plants, to incredibly complex new therapies composed of engineered cells and genes. And that's just the very beginning....
16 Minutes on the News #43: A Nobel for CRISPR! Who, When, How - Andreessen Horowitz
The Nobel Prize in Chemistry was awarded this week to Emmanuelle Charpentier and Jennifer Doudna for the revolutionary CRISPR/Cas9 "genetic scissors" technology for genome editing. But is that analogy too limited for describing the true power and...
a16z Podcast: How to Decide, Convey vs. Convince, & More - Andreessen Horowitz
All kinds of decisions, whether in life or business -- like marriage product management, what to eat or watch -- are a portfolio of investments. And obviously, not all decisions are equal; in fact, sometimes we don't even have to spend any time...
BioAge Discovers Key Pathway and Identifies Promising Phase 2 Ready Drug to Treat and Reverse Immune Aging, a Root Cause of COVID-19 Morbidity and Mortality in Older Patients
BioAge Plans Phase 2 Clinical trial in Hospitalized COVID-19 Patients Clinical development plan supported by potent inhibition of PGD2 DP1 Receptor by...
Vijay Pande
3/ And moreover, with immune aging being another natural area of immediate therapeutic impact.
105d
Vijay Pande
2/ In fact, COVID-19 is a natural and immediate example of the power of this approach –– with aging insights leading to a clinical-stage therapy with significant promise and potential in treating immune aging in older patients hospitalized with COVID-19.
105d
The Cure for Aging Might be the Cure for Alzheimer’s - Andreessen Horowitz
What we are only now beginning to understand is that the diseases that ultimately kill us are inseparable from the aging process itself. Aging is the root cause. This means that studying these diseases without taking aging into account could be...
1
Vijay Pande
1/ Understanding how we age is a way into a new era of medicine, into identifying new targets for diseases we’ve never truly understood (let alone known how to treat).
The cure for aging just might be the cure for disease.
@kpfortney @bioagelabs @a16z
105d
Two CRISPR scientists win Nobel Prize in chemistry - STAT
Emmanuelle Charpentier of the Max Planck Institute and Jennifer Doudna of the University of California have won for their CRISPR discovery.
The Nobel Prize in Chemistry 2020
The Nobel Prize in Chemistry 2020 was awarded jointly to Emmanuelle Charpentier and Jennifer A. Doudna "for the development of a method for genome editing".
4
Vijay Pande
Congratulations to Jennifer Doudna @doudna_lab and Emmanuelle Charpentier for their 2020 Nobel Prize in Chemistry "for the development of a method for genome editing."
106d
Starting with Biogen deal in ALS, Scribe planning a new chapter in CRISPR story
Scribe Therapeutics Inc., another CRISPR-based genome editing firm out of the Jennifer Doudna stable, launched with $20 million in series A funding and a deal with Biogen Inc. in amyotrophic lateral sclerosis (ALS), which brings in another $15...
Bio Eats World: Going Back to the Workplace in a Pandemic - Andreessen Horowitz
It's not normal to talk to your employer about the details of your health: your current temperature, who you've been exposed to, whether your kid is sick, whether or not you've been social distancing. So how do employers handle and manage this...
Scribe Therapeutics Unveils Fully Integrated Platform for Engineering Breakthrough CRISPR-based Genetic Medicines
Scribe Therapeutics unveils fully integrated platform for engineering breakthrough CRISPR-based genetic medicines, Series A, and Biogen collaboration
Biogen, gene-editing startup Scribe to develop therapies for Lou Gehrig's disease
U.S. drugmaker Biogen Inc and gene-editing startup Scribe Therapeutics Inc will jointly develop therapies for treating underlying genetic causes of amyotrophic lateral sclerosis (ALS), a fatal neurological disorder better known as Lou Gehrig's...
Vijay Pande
Congrats @scribetx on your deal with @biogen to jointly develop therapies for treating underlying genetic causes of amyotrophic lateral sclerosis (ALS), aka Lou Gehrig’s disease––a natural place where CRISPR-based therapeutics could have major impact.
107d
Bio Eats World: Revolutions in Cancer Treatment—Past, Present, and Future - Andreessen Horowitz
In this episode of Bio Eats World, we explore all the major revolutions in cancer treatment across the history of medicine—and what’s coming next. Hanne Winarsky delves into the past and future of the fight against cancer with Gary Reedy, …
Investing in Scribe Therapeutics - Andreessen Horowitz
Scribe was founded and is directed by CRISPR pioneers and expert molecular engineers, including CRISPR icon and co-discoverer Prof. Jennifer Douda, PhD and her UC Berkeley collaborators Benjamin Oakes, PhD, Brett Staahl, PhD, and Prof. David Savage,...
4
Vijay Pande
1/ I am thrilled to announce that @a16z has led Scribe's $20M Series A investment round and that I have joined their board of directors. Today I am excited to see Scribe unveil their mission and progress to the broader community.
107d
insitro Adds Biopharma Industry Leader Roger Perlmutter as First Independent Board Member
insitro, a machine-learning driven drug discovery and development company, today announced the appointment of Roger Perlmutter, M.D., Ph.D., executive